Aaron P Mitchell (Aaron Mitchell)

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 29

Top Venues

The oncologist

JCO oncology practice

JNCI cancer spectrum

BMJ medicine

Memorial Sloan Kettering Cancer Center

Yale University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Memorial Sloan Kettering Cancer Center Aug 06 2018

United States

Assistant Attending :: Epidemiology and Biostatistics

Duke University Hospital

United States

Resident :: Internal Medicine

Education History

Yale University

United States

BSC

Publications

Nirjhar Chakraborty, Meredith Brown, Sonia Persaud, Grace Gallagher, Niti U Trivedi, Peter B Bach, Aaron P Mitchell
Trends in financial payments from industry to US cancer centers, 2014-2021. JNCI cancer spectrum 8 (3) (2024)
Aaron P Mitchell, David Nemirovsky, Akriti Mishra Meza, Nirjhar Chakraborty, Sonia Persaud, Azeez Farooki, Michael J Morris
Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer. JCO oncology practice (2024)
Nirjhar Chakraborty, Meredith Brown, Sonia Persaud, Grace Gallagher, Niti U Trivedi, Peter B Bach, Aaron P Mitchell
Trends in financial payments from industry to US cancer centers, 2014-2021. JNCI cancer spectrum 8 (3) (2024)
Aaron P Mitchell, David Nemirovsky, Akriti Mishra Meza, Nirjhar Chakraborty, Sonia Persaud, Azeez Farooki, Michael J Morris
Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer. JCO oncology practice 20 (3) (2024)
Aaron P Mitchell, Alan C Kinlaw, Sharon Peacock-Hinton, Stacie B Dusetzina, Aaron N Winn, Hanna K Sanoff, Jennifer L Lund
Commercial Versus Medicaid Insurance and Use of High-Priced Anticancer Treatments. The oncologist 29 (6) (2024)
Aaron P Mitchell, David Nemirovsky, Akriti Mishra Meza, Nirjhar Chakraborty, Sonia Persaud, Azeez Farooki, Michael J Morris
Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer. JCO oncology practice (2024)
Maryam Mooghali, Aaron P Mitchell, Joshua J Skydel, Joseph R Ross, Joshua D Wallach, Reshma Ramachandran
Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: cross sectional study. BMJ medicine 3 (1) (2024)
Aaron P Mitchell, David Nemirovsky, Akriti Mishra Meza, Nirjhar Chakraborty, Sonia Persaud, Azeez Farooki, Michael J Morris
Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer. JCO oncology practice 20 (3) (2024)
Maryam Mooghali, Aaron P Mitchell, Joshua J Skydel, Joseph R Ross, Joshua D Wallach, Reshma Ramachandran
Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: cross sectional study. BMJ medicine 3 (1) (2024)
Aaron P Mitchell, Alan C Kinlaw, Sharon Peacock-Hinton, Stacie B Dusetzina, Aaron N Winn, Hanna K Sanoff, Jennifer L Lund
Commercial Versus Medicaid Insurance and Use of High-Priced Anticancer Treatments. The oncologist (2024)
Aaron P Mitchell, David Nemirovsky, Akriti Mishra Meza, Nirjhar Chakraborty, Sonia Persaud, Azeez Farooki, Michael J Morris
Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer. JCO oncology practice 20 (3) (2024)
Aaron P Mitchell, Alan C Kinlaw, Sharon Peacock-Hinton, Stacie B Dusetzina, Aaron N Winn, Hanna K Sanoff, Jennifer L Lund
Commercial Versus Medicaid Insurance and Use of High-Priced Anticancer Treatments. The oncologist 29 (6) (2024)
Nirjhar Chakraborty, Meredith Brown, Sonia Persaud, Grace Gallagher, Niti U Trivedi, Peter B Bach, Aaron P Mitchell
Trends in financial payments from industry to US cancer centers, 2014-2021. JNCI cancer spectrum 8 (3) (2024)
Nirjhar Chakraborty, Meredith Brown, Sonia Persaud, Grace Gallagher, Niti U Trivedi, Peter B Bach, Aaron P Mitchell
Trends in financial payments from industry to US cancer centers, 2014-2021. JNCI cancer spectrum 8 (3) (2024)
Maryam Mooghali, Aaron P Mitchell, Joshua J Skydel, Joseph R Ross, Joshua D Wallach, Reshma Ramachandran
Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehensive Cancer Network: cross sectional study. BMJ medicine 3 (1) (2024)
Aaron P Mitchell, Alan C Kinlaw, Sharon Peacock-Hinton, Stacie B Dusetzina, Aaron N Winn, Hanna K Sanoff, Jennifer L Lund
Commercial Versus Medicaid Insurance and Use of High-Priced Anticancer Treatments. The oncologist 29 (6) (2024)
Aaron P Mitchell, David Nemirovsky, Akriti Mishra Meza, Nirjhar Chakraborty, Sonia Persaud, Azeez Farooki, Michael J Morris
Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer. JCO oncology practice 20 (3) (2024)
Aaron P Mitchell, Alan C Kinlaw, Sharon Peacock-Hinton, Stacie B Dusetzina, Aaron N Winn, Hanna K Sanoff, Jennifer L Lund
Commercial Versus Medicaid Insurance and Use of High-Priced Anticancer Treatments. The oncologist (2024)
Aaron P Mitchell, Stacie B Dusetzina, Akriti Mishra Meza, Niti U Trivedi, Aaron N Winn, Aaron N Winn
Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort study. BMJ (Clinical research ed.) 383 (2023)
Erin F Gillespie, Joanna C Yang, Noah J Mathis, Catherine B Marine, Charlie White, Zhigang Zhang, Christopher A Barker, Rupesh R Kotecha, Alyson McIntosh, Max Vaynrub, Meredith K Bartelstein, Aaron P Mitchell, David M Guttmann, Divya Yerramilli, Daniel S Higginson, Yoshida J Yamada, Zachary A Kohutek, Simon N Powell, Chiaojung Jillian Tsai, Jonathan T Yang
Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Aaron P Mitchell, Sonia Persaud, Paul Palyca, Andrew Salner, Azeez Farooki, Jamie S Ostroff, Michael J Morris, Susan Chimonas
Physician knowledge, practice patterns, and barriers encountered regarding guideline-concordant use of bone modifying agents for prostate cancer. The Prostate (2023)
Aaron P Mitchell, Akriti Mishra Meza, Katherine S Panageas, Allison Lipitz-Snyderman, Azeez Farooki, Michael J Morris
Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2022)
Aaron P Mitchell, Akriti Mishra Meza, Niti U Trivedi, Peter B Bach, Mithat Gönen
Physician Payments from Pharmaceutical Companies Related to Cancer Drugs. The oncologist 27 (10) (2022)
Aaron P Mitchell, Daniel A Goldstein
Cost Savings and Increased Access With Ultra-Low-Dose Immunotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Aaron P Mitchell, Akriti Mishra, Pranam Dey, Michael A Curry, Niti U Trivedi, Michael Haddadin, Mohammed W Rahman, Aaron N Winn, Stacie B Dusetzina, Peter B Bach
Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines. The oncologist 26 (9) (2021)
Aaron P Mitchell
Industry Payments to Rheumatologists Ought to Be Going Down, Not Up. Arthritis & rheumatology (Hoboken, N.J.) 73 (11) (2021)
Aaron P Mitchell
We Should Treat Financial Toxicity With Curative, Rather Than Palliative, Intent. JCO oncology practice (2021)
Aaron P Mitchell, Niti U Trivedi, Renee L Gennarelli, Susan Chimonas, Sara M Tabatabai, Johanna Goldberg, Luis A Diaz, Deborah Korenstein
Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? : A Systematic Review. Annals of internal medicine 174 (3) (2020)
Aaron P Mitchell, Alan C Kinlaw, Sharon Peacock-Hinton, Stacie B Dusetzina, Hanna K Sanoff, Jennifer L Lund
Use of High-Cost Cancer Treatments in Academic and Nonacademic Practice. The oncologist 25 (1) (2019)
Ryan David Nipp, Aaron P Mitchell, Allyson M Pishko, Ara Metjian
Waldenström macroglobulinemia in hepatitis C: case report and review of the current literature. Case reports in oncological medicine 2014 (2014)

Aaron P Mitchell.css-eqlu8i{font-size:small;padding-left:4px;} (Aaron Mitchell)

Publication Activity (10 Years)

Top Topics

Top Venues

Aaron P Mitchell (Aaron Mitchell)